Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism-Reference-Cited by-同舟云学术

Bioavailability and Pharmacokinetics of Endoxifen in Female Rats and Dogs: Evidence to Support the Use of Endoxifen to Overcome the Limitations of CYP2D6-Mediated Tamoxifen Metabolism

Published:2022-11-09 Issue:2 Volume:51 Page:183-192
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Koubek Emily J.,Buhrow Sarah A.,Safgren Stephanie L.,Jia Lee,Goetz Matthew P.,Ames Matthew M.,Reid Joel M.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference39 articles.

1. Orally administered Endoxifen is a new therapeutic agent for breast cancer

2. Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment

3. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin

4. Canine cytochrome P-450 pharmacogenetics;Court;Vet Clin North Am Small Anim Pract,2013

5. Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenoxyalkyl cyclic and acyclic amine derivatives: what do they teach us about scaffold-based drug design?;Medicinal Chemistry Research;2024-04-10

2. Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS/MS in human plasma and its application to therapeutic drug monitoring in cancer patients;Journal of Chromatography B;2024-04